A long-acting injectable antiretroviral drug administered once every two months is "safe and superior" to daily pills taken by women to protect them from contracting HIV, a new study conducted in seven African countries including Zimbabwe …
Published: 10 Nov 2020 at 19:43hrs | 2 | by Staff reporter